» Articles » PMID: 28408903

Anti-bacterial and Anti-biofilm Evaluation of Thiazolopyrimidinone Derivatives Targeting the Histidine Kinase YycG Protein of

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2017 Apr 15
PMID 28408903
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Staphylococcus epidermidis is one of the most important opportunistic pathogens in nosocomial infections. The main pathogenicity associated with involves the formation of biofilms on implanted medical devices, biofilms dramatically decrease the efficacy of conventional antibiotics and the host immune system. This emphasizes the urgent need for designing novel anti-staphylococcal biofilm agents. Based on the findings that compound 5, targeting the histidine kinase domain of YycG, possessed bactericidal activity against staphylococci, 39 derivatives of compound 5 with intact thiazolopyrimidinone core structures were newly designed, 7 derivatives were further screened to explore their anti-bacterial and anti-biofilm activities. The seven derivatives strongly inhibited the growth of and in the minimal inhibitory concentration range of 1.56-6.25 μM. All the derivatives reduced the proportion of viable cells in mature biofilms. They all displayed low cytotoxicity on mammalian cells and were not hemolytic to human erythrocytes. The biofilm inhibition activities of four derivatives (H5-32, H5-33, H5-34, and H5-35) were further investigated under shearing forces, they all led to significant decreases in the biofilm formation of . These results were suggestive that the seven derivatives of compound 5 have the potential to be developed into agents for eradicating biofilm-associated infections.

Citing Articles

The ArlS Kinase Inhibitor Tilmicosin Has Potent Anti-Biofilm Activity in Both Static and Flow Conditions.

Wang Z, Wang H, Bai J, Cai S, Qu D, Xie Y Microorganisms. 2024; 12(2).

PMID: 38399660 PMC: 10891534. DOI: 10.3390/microorganisms12020256.


Antimicrobial and anti-biofilm activity of a thiazolidinone derivative against and .

Zhao R, Du B, Luo Y, Xue F, Wang H, Qu D Microbiol Spectr. 2024; 12(3):e0232723.

PMID: 38329365 PMC: 10913468. DOI: 10.1128/spectrum.02327-23.


Recent Advances in Histidine Kinase-Targeted Antimicrobial Agents.

Chen H, Yu C, Wu H, Li G, Li C, Hong W Front Chem. 2022; 10:866392.

PMID: 35860627 PMC: 9289397. DOI: 10.3389/fchem.2022.866392.


In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains.

Chen Z, Xiong Y, Tang Y, Zhao Y, Chen J, Zheng J BMC Microbiol. 2022; 22(1):16.

PMID: 34996348 PMC: 8740470. DOI: 10.1186/s12866-021-02423-8.


Monoclonal Antibodies Specific to the Extracellular Domain of Histidine Kinase YycG of Inhibit Biofilm Formation.

Lyu Z, Shang Y, Wang X, Wu Y, Zheng J, Liu H Front Microbiol. 2020; 11:1839.

PMID: 32849437 PMC: 7426370. DOI: 10.3389/fmicb.2020.01839.


References
1.
Silver L . Challenges of antibacterial discovery. Clin Microbiol Rev. 2011; 24(1):71-109. PMC: 3021209. DOI: 10.1128/CMR.00030-10. View

2.
Liu H, Zhao D, Chang J, Yan L, Zhao F, Wu Y . Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol. 2014; 98(13):6003-13. PMC: 4057637. DOI: 10.1007/s00253-014-5685-8. View

3.
Raad I, Alrahwan A, Rolston K . Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998; 26(5):1182-7. DOI: 10.1086/520285. View

4.
Pridmore A, Burch D, Lees P . Determination of minimum inhibitory and minimum bactericidal concentrations of tiamulin against field isolates of Actinobacillus pleuropneumoniae. Vet Microbiol. 2011; 151(3-4):409-12. DOI: 10.1016/j.vetmic.2011.03.016. View

5.
Imaizumi T, Tran H, Swartz T, Briggs W, Kay S . FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis. Nature. 2003; 426(6964):302-6. DOI: 10.1038/nature02090. View